WB
DGX icon

West Bancorporation’s Quest Diagnostics DGX Stock Holding History

West Bancorporation’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,101
Closed -$169K – 297
2020
Q1 		$169K Buy
2,101
+48
+2% +$4.97K 0.23% 66
2019
Q4 		$219K Buy
+2,053
New +$214K 0.22% 70

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

West Bancorporation's DGX Position: Q2 2020 in Review

West Bancorporation sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 2,101 shares — an estimated $169K sold.

West Bancorporation first reported a position in DGX in Q4 2019 and held it in 2 quarters. The position peaked at $219K in Q4 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • West Bancorporation reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • West Bancorporation sold 2,101 Quest Diagnostics shares in Q2 2020, an estimated $169K.
  • West Bancorporation first reported a position in Quest Diagnostics in Q4 2019 and held it in 2 quarters.
  • West Bancorporation's Quest Diagnostics position peaked at $219K in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on West Bancorporation's 13F filing for Q2 2020, filed 31 Jul 2020.